Selçuk Demiral

3.2k citations

91 papers · 2.4k indexed · h-index 33

Pulmonary and Respiratory Medicine top 5%
Genetics top 1%
Surgery top 5%
Radiology, Nuclear Medicine and Imaging top 5%
Epidemiology top 5%

Co-authors: Murat Beyzadeoğlu Ömer Sağer Ferrat Dinçoğlan Bora Uysal Hakan Gamsız Bahar Dırıcan Kaan Oysul Sait Şirin
Topics: Glioma Diagnosis and Treatment (28 papers)Advanced Radiotherapy Techniques (24 papers)Brain Metastases and Treatment (22 papers)
Cited by: Genetics Otorhinolaryngology Radiation
Journals: Journal of Pain and Symptom Management Asian Pacific Journal of Cancer Prevention World Journal of Clinical Oncology
Partner nations: Türkiye Antigua and Barbuda Somalia

In The Last Decade

Selçuk Demiral

88 papers receiving 2.3k citations

Peers

Countries citing papers authored by Selçuk Demiral

Since Specialization

Citations

This map shows the geographic impact of Selçuk Demiral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selçuk Demiral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selçuk Demiral more than expected).

Fields of papers citing papers by Selçuk Demiral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selçuk Demiral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selçuk Demiral. The network helps show where Selçuk Demiral may publish in the future.

Co-authorship network of co-authors of Selçuk Demiral

This figure shows the co-authorship network connecting the top 25 collaborators of Selçuk Demiral. A scholar is included among the top collaborators of Selçuk Demiral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selçuk Demiral. Selçuk Demiral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Size Changes after Neoadjuvant Systemic Therapy for Advanced Oropharyngeal Squamous Cell Carcinoma 2023 ·Selçuk Demiral	2
2	Target Definitionoforbital Embryonal Rhabdomyosarcoma (Rms) by Multimodality Imaging: An Original Article 2021 ·Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	6
3	Multimodality Imaging Based Target Definition of Cervical Lymph Nodes in Precise Limited Field Radiation Therapy (Lfrt) for Nodular Lymphocyte Predominant Hodgkin Lymphoma (Nlphl) 2021 ·Selçuk Demiral,Ferrat Dinçoğlan,Ömer Sağer,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	24
4	Multimodality Imaging Based Treatment Volume Definition for Reirradiation of Recurrent Small Cell Lung Cancer (SCLC) 2021 ·Zenodo (CERN European Organization for Nuclear Research) ·Ömer Sağer,Selçuk Demiral,Ferrat Dinçoğlan,Murat Beyzadeoğlu	15
5	Assessment of Treatment Volume Definition for Irradiation of Spinal Ependymomas: an Original Article 2020 ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Selçuk Demiral,Ömer Sağer,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	31
6	Evaluation of Target Volume Determination for Irradiation of Pilocytic Astrocytomas: An Original Article 2020 ·Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	6
7	8 Gy single dose radiotherapy for bone metastasis in COVID-19 pandemia period: Review 2020 ·Bora Uysal,Hakan Gamsız,Ferrat Dinçoğlan,Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu	0
8	Radiation Therapy (RT) for Diffuse Intrinsic Pontine Glioma (DIPG) in Children 2018 ·Zenodo (CERN European Organization for Nuclear Research) ·Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,(unknown),Faruk Özcan,Esin Gündem,Yelda Elcim,(unknown),(unknown),Bahar Dırıcan,Murat Beyzadeoğlu	3
9	Castleman′s disease and radiotherapy: A single center experience 2015 ·Journal of Cancer Research and Therapeutics ·Bora Uysal,Selçuk Demiral,Hakan Gamsız,Ferrat Dinçoğlan,Ömer Sağer,Murat Beyzadeoğlu	7
10	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of glomus jugulare tumors. 2014 ·PubMed ·Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Hakan Gamsız,Selçuk Demiral,Bora Uysal,Kaan Oysul,Bahar Dırıcan,Sait Şirin	25
11	Management of pulmonary oligometastases by stereotactic body radiotherapy. 2014 ·PubMed ·Hakan Gamsız,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Serdar Sürenkök,Kaan Oysul,Bahar Dırıcan	19
12	Role of radiotherapy in the management of heel spur 2014 ·European Journal of Orthopaedic Surgery & Traumatology ·Bora Uysal,Murat Beyzadeoğlu,Ömer Sağer,Selçuk Demiral,Hakan Gamsız,Ferrat Dinçoğlan,Mustafa Akın,Bahar Dırıcan	9
13	Evaluation of Treatment Outcomes of Early-Stage Endometrial Cancer Radiotherapy: A Single Center Experience 2014 ·Asian Pacific Journal of Cancer Prevention ·Selçuk Demiral,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Mustafa Akın,(unknown),Bahar Dırıcan	4
14	Radiotherapy for Perianal Extramammary Paget's Disease: A case report 2013 ·Selçuk Demiral,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Serdar Sürenkök,Kaan Oysul,Sezai Demırbaş,Murat Demiriz,Murat Beyzadeoğlu	0
15	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of meningiomas: a single center experience. 2013 ·PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Bora Uysal,Selçuk Demiral,Hakan Gamsız,Bahar Dırıcan	54
16	Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique. 2013 ·PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Kaan Oysul,(unknown),Hakan Gamsız,Bora Uysal,Selçuk Demiral,Bahar Dırıcan,Serdar Sürenkök	21
17	Evaluation of stereotactic body radiotherapy (sbrt) boost in the management of endometrial cancer 2013 ·Neoplasma ·Selçuk Demiral,Murat Beyzadeoğlu,Bora Uysal,Kaan Oysul,(unknown),Ömer Sağer,Ferrat Dinçoğlan,Hakan Gamsız,Bahar Dırıcan,Serdar Sürenkök	56
18	Dosimetric Evaluation of Intensity Modulated Radiotherapy and 4-Field 3-D Conformal Radiotherapy in Prostate Cancer Treatment 2012 ·Balkan Medical Journal ·Bora Uysal,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Hakan Gamsız,Serdar Sürenkök,Kaan Oysul	19
19	A Concise Review of High Dose Rate (HDR) Brachytherapy (BT) Boost as part of Breast Conserving Treatment (BCT) for Breast Cancer (BC) 2005 ·Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Hakan Gamsız	1
20	RADIOSURGERY TREATMENT VOLUME DETERMINATION FOR BRAIN LYMPHOMAS WITH AND WITHOUT INCORPORATION OF MULTIMODALITY IMAGING 2005 ·Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu	32

About Selçuk Demiral

Selçuk Demiral is a scholar working on Radiation, Genetics and Pulmonary and Respiratory Medicine, having authored 91 papers that have together received 2.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Advanced Radiotherapy Techniques (24 papers) and Brain Metastases and Treatment (22 papers). The work is most often cited by research in Genetics (749 citations), Otorhinolaryngology (276 citations) and Radiation (287 citations). Selçuk Demiral has collaborated with scholars based in Türkiye, Antigua and Barbuda and Somalia. Frequent co-authors include Murat Beyzadeoğlu, Ömer Sağer, Ferrat Dinçoğlan, Bora Uysal, Hakan Gamsız, Bahar Dırıcan, Kaan Oysul, Sait Şirin, Serdar Sürenkök and Fatih Özcan. Their work appears in journals such as Journal of Pain and Symptom Management, Asian Pacific Journal of Cancer Prevention and World Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact